Cite
HARVARD Citation
Burmester, G. et al. (n.d.). OP0034 Efficacy and Safety of Mavrilimumab, A Fully Human Gm–CSFR-Alpha Monoclonal Antibody in Patients with Rheumatoid Arthritis: Primary Results from the Earth Explorer 1 Study. Annals of the rheumatic diseases. p. 78. [Online].